PIK3CA and breast cancer: Here we present results of analyses on the prognostic and predictive value of specific tumor-associated lymphocytes in the context of PI3K alterations, using data from a trial in which breast cancer patients were randomized between adjuvant tamoxifen and no endocrine treatment.